Nathan Treybeck
Stock Analyst at Wells Fargo
(2.55)
# 2,356
Out of 5,090 analysts
21
Total ratings
42.86%
Success rate
7.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $97 → $93 | $84.53 | +10.02% | 2 | Nov 7, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $58 → $51 | $35.86 | +42.22% | 9 | Nov 5, 2025 | |
| ITGR Integer Holdings | Downgrades: Equal-Weight | $132 → $80 | $69.84 | +14.55% | 4 | Oct 24, 2025 | |
| RMD ResMed | Initiates: Equal-Weight | $280 | $256.55 | +9.14% | 1 | Oct 13, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $130 → $180 | $178.37 | +0.91% | 5 | Aug 1, 2025 |
LeMaitre Vascular
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $97 → $93
Current: $84.53
Upside: +10.02%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Overweight
Price Target: $58 → $51
Current: $35.86
Upside: +42.22%
Integer Holdings
Oct 24, 2025
Downgrades: Equal-Weight
Price Target: $132 → $80
Current: $69.84
Upside: +14.55%
ResMed
Oct 13, 2025
Initiates: Equal-Weight
Price Target: $280
Current: $256.55
Upside: +9.14%
iRhythm Technologies
Aug 1, 2025
Maintains: Overweight
Price Target: $130 → $180
Current: $178.37
Upside: +0.91%